Sci Show: A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial.

Sunday, July 11, 2021

A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial.

https://ift.tt/3qZJYs2 via /r/science https://ift.tt/3hWb8vO

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)